Search

Peter Anthopolos

Examiner (ID: 5946, Phone: (571)270-5989 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
1611
Total Applications
621
Issued Applications
329
Pending Applications
62
Abandoned Applications
247

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19510422 [patent_doc_number] => 20240342108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES [patent_app_type] => utility [patent_app_number] => 18/134980 [patent_app_country] => US [patent_app_date] => 2023-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134980 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/134980
GREEN METHOD OF PRODUCING CIRCLE-SHAPED SILVER NANOPARTICLES USING ETHYL ACETATE EXTRACT OF URTICA DIOICA LEAVES Apr 13, 2023 Pending
Array ( [id] => 18496123 [patent_doc_number] => 20230218667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES [patent_app_type] => utility [patent_app_number] => 18/122478 [patent_app_country] => US [patent_app_date] => 2023-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13463 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122478 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/122478
Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses Mar 15, 2023 Issued
Array ( [id] => 19884101 [patent_doc_number] => 12269793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-08 [patent_title] => Affinity illudofulvene conjugates [patent_app_type] => utility [patent_app_number] => 18/175495 [patent_app_country] => US [patent_app_date] => 2023-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 56 [patent_no_of_words] => 42426 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175495 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/175495
Affinity illudofulvene conjugates Feb 26, 2023 Issued
Array ( [id] => 18449382 [patent_doc_number] => 20230190658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 18/112747 [patent_app_country] => US [patent_app_date] => 2023-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112747 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/112747
MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME Feb 21, 2023 Abandoned
Array ( [id] => 19440007 [patent_doc_number] => 12090234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Compositions and methods related to megakaryocyte-derived extracellular vesicles [patent_app_type] => utility [patent_app_number] => 18/100821 [patent_app_country] => US [patent_app_date] => 2023-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 33 [patent_no_of_words] => 49079 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100821 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/100821
Compositions and methods related to megakaryocyte-derived extracellular vesicles Jan 23, 2023 Issued
Array ( [id] => 20057341 [patent_doc_number] => 20250195563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/730182 [patent_app_country] => US [patent_app_date] => 2023-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18730182 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/730182
METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES Jan 18, 2023 Pending
Array ( [id] => 18449652 [patent_doc_number] => 20230190928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CONTROLLED RELEASE VACCINE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/154304 [patent_app_country] => US [patent_app_date] => 2023-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154304 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/154304
CONTROLLED RELEASE VACCINE FORMULATION Jan 12, 2023 Abandoned
Array ( [id] => 19798826 [patent_doc_number] => 20250064751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => STABLE FORMULATIONS OF LIPID-ENCAPSULATED RNA [patent_app_type] => utility [patent_app_number] => 18/726667 [patent_app_country] => US [patent_app_date] => 2023-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726667 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/726667
STABLE FORMULATIONS OF LIPID-ENCAPSULATED RNA Jan 8, 2023 Pending
Array ( [id] => 19798921 [patent_doc_number] => 20250064846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA [patent_app_type] => utility [patent_app_number] => 18/726735 [patent_app_country] => US [patent_app_date] => 2023-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726735 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/726735
TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA Jan 5, 2023 Pending
Array ( [id] => 18365954 [patent_doc_number] => 20230147545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => SHEET-SHAPED MEMBER [patent_app_type] => utility [patent_app_number] => 18/091176 [patent_app_country] => US [patent_app_date] => 2022-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091176 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/091176
Sheet-shaped member Dec 28, 2022 Issued
Array ( [id] => 18339947 [patent_doc_number] => 20230131896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => COSMETIC COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/086725 [patent_app_country] => US [patent_app_date] => 2022-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6623 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086725 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/086725
Cosmetic compositions and methods of use Dec 21, 2022 Issued
Array ( [id] => 18449771 [patent_doc_number] => 20230191047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS [patent_app_type] => utility [patent_app_number] => 18/082311 [patent_app_country] => US [patent_app_date] => 2022-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082311 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/082311
Medical counter measures including dry powder formulations and associated methods Dec 14, 2022 Issued
Array ( [id] => 18365926 [patent_doc_number] => 20230147517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/076012 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076012 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/076012
LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF Dec 5, 2022 Abandoned
Array ( [id] => 18466983 [patent_doc_number] => 20230201263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR [patent_app_type] => utility [patent_app_number] => 18/071010 [patent_app_country] => US [patent_app_date] => 2022-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18071010 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/071010
Pretreatment drug for T cell infusion therapy for immune-checkpoint inhibitor-resistant tumor Nov 28, 2022 Issued
Array ( [id] => 18197303 [patent_doc_number] => 20230050822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING BIOFILMS [patent_app_type] => utility [patent_app_number] => 17/970906 [patent_app_country] => US [patent_app_date] => 2022-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970906 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/970906
COMPOSITIONS AND METHODS FOR TREATING BIOFILMS Oct 20, 2022 Abandoned
Array ( [id] => 18325342 [patent_doc_number] => 20230123470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => MICROENCAPSULATION OF NICOTINE FOR TOBACCOLESS ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/047375 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047375 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047375
MICROENCAPSULATION OF NICOTINE FOR TOBACCOLESS ORAL ADMINISTRATION Oct 17, 2022 Abandoned
Array ( [id] => 18278579 [patent_doc_number] => 20230094051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS [patent_app_type] => utility [patent_app_number] => 17/957640 [patent_app_country] => US [patent_app_date] => 2022-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957640 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/957640
DIMETHYLTRIPTAMINE-BASED NASAL SPRAY FOR THE PERSONALISED TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS Sep 29, 2022 Abandoned
Array ( [id] => 18091180 [patent_doc_number] => 20220409521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => COMPOSITION FOR COSMETICS [patent_app_type] => utility [patent_app_number] => 17/902742 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7235 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/902742
COMPOSITION FOR COSMETICS Sep 1, 2022 Abandoned
Array ( [id] => 18544151 [patent_doc_number] => 11717482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Inhalable antimicrobial particles and methods of making the same [patent_app_type] => utility [patent_app_number] => 17/823239 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23293 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823239 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/823239
Inhalable antimicrobial particles and methods of making the same Aug 29, 2022 Issued
Array ( [id] => 18328181 [patent_doc_number] => 11633396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one [patent_app_type] => utility [patent_app_number] => 17/821833 [patent_app_country] => US [patent_app_date] => 2022-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 14105 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821833 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/821833
Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one Aug 23, 2022 Issued
Menu